Real-time enrollment status for this platinum-resistant fallopian tube carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:32 PM UTC
| NCT Number | NCT05538091 |
| Recruiting Status | Recruiting |
| Condition | Platinum-Resistant Fallopian Tube Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 48 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ronald Buckanovich |
| Last Updated on CT.gov | June 18, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT05538091 is currently recruiting participants. This clinical trial study for platinum-resistant fallopian tube carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Ronald Buckanovich. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05538091 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05538091 was last updated 3 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.